The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets.
Philip H. Kim
No relevant relationships to disclose
John P. Sfakianos
No relevant relationships to disclose
Sasinya N. Scott
No relevant relationships to disclose
Gopa Iyer
No relevant relationships to disclose
Eugene K. Cha
No relevant relationships to disclose
Hikmat Al-Ahmadie
No relevant relationships to disclose
Arony J. Sun
No relevant relationships to disclose
Ilana Rebecca Garcia-Grossman
No relevant relationships to disclose
Richard Martin Bambury
No relevant relationships to disclose
Guido Dalbagni
No relevant relationships to disclose
Jonathan E. Rosenberg
No relevant relationships to disclose
Dean F. Bajorin
No relevant relationships to disclose
Michael F. Berger
No relevant relationships to disclose
David B. Solit
No relevant relationships to disclose
Bernard H. Bochner
No relevant relationships to disclose